You are here
Singapore-based firm on track to commercialise cancer drug
SCIENTISTS are now a step closer to turning cancer patients' own immune cells (T-cells) against the tumours in their bodies - and possibly finding a cure for the dreaded disease.
A Singapore-based biotechnology firm has emerged ahead of the very crowded research field of
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org